DANCR and acute myeloid leukemia: Studies have shown that the knockdown of lncRNA DANCR can reduce the invasiveness of AML. Kong Wenyan et al. confirmed that lncRNA DANCR regulates the cell cycle of AML cells by targeting miR-656-3p. DANCR has significant potential as a therapeutic target for AML (Bill et al., 2019; Kong et al., 2022).